New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir

View source ↗

Summary

A new EMA study suggests a potential increased risk of birth defects in babies born to women taking the HIV medicine dolutegravir; further investigation and age…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Birth Defects
• HIV Infection in Pregnant Women

Drugs mentioned

• Dolutegravir (dolutegravir)